H. Res. 1060 (119th)Bill Overview

Expressing support for the designation of April 5, 2026, as "Barth Syndrome Awareness Day".

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Feb 11, 2026
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief

This House resolution expresses support for designating April 5, 2026, as Barth Syndrome Awareness Day.

It explains Barth syndrome’s clinical features, prevalence, and challenges, notes the need for research and diagnostics, and recognizes relevant actors like the Barth Syndrome Foundation and Kennedy Krieger Institute.

The resolution also highlights the role of the Orphan Drug Act and FDA patient-focused programs and encourages attention to regulatory pathways for ultrarare disease drug development.

Passage0/100

Text is a nonbinding House resolution that does not create law; adoption by the House likely, but it cannot become law as written.

CredibilityAligned

Relative to its intended legislative type, this bill functions as a conventional commemorative resolution: it provides a substantive factual preamble and then issues declarative support for designating April 5, 2026 as Barth Syndrome Awareness Day while listing awareness and research priorities. The level of operational, fiscal, and legal detail is minimal but appropriate for a symbolic designation.

Contention8/100

Left emphasizes need for funding and access commitments

02 · What it does

Who stands to gain, and who may push back.

Who this appears to help vs burden50% / 50%
Targeted stakeholdersTargeted stakeholders
Likely helped
  • Targeted stakeholdersRaises national public awareness of Barth syndrome, increasing visibility for patients, caregivers, and clinicians.
  • Targeted stakeholdersMay encourage earlier diagnosis and referral to specialized clinics and multidisciplinary care teams.
  • Targeted stakeholdersCould attract research interest and philanthropic funding toward ultrarare disease studies and therapy development.
Likely burdened
  • Targeted stakeholdersThe resolution is symbolic and creates no new funding, legal mandates, or entitlement programs.
  • Targeted stakeholdersUnlikely to produce immediate clinical treatments, FDA approvals, or measurable health outcomes.
  • Targeted stakeholdersMay raise patient and caregiver expectations for rapid policy or therapeutic advances without resources.
03 · Why people split

Why the argument around this bill splits.

Left emphasizes need for funding and access commitments
Progressive98%

Likely welcomes the resolution as a compassionate, patient-centered recognition of a rare disease and a prompt to accelerate research.

Would emphasize the need for federal support, equitable access to care, and incorporating patient perspectives into drug development.

Leans supportive
Centrist95%

Likely supportive of the nonbinding, awareness-focused resolution while wanting clear limits on fiscal or regulatory commitments.

Views it as a reasonable, low-cost way to spotlight unmet medical needs, but seeks practical follow-up steps.

Leans supportive
Conservative88%

Generally supportive of an awareness day for a rare, life-threatening disease but cautious about language implying regulatory or budgetary change.

Prefers symbolic recognition without new federal obligations or expanded bureaucratic programs.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood0/100

Text is a nonbinding House resolution that does not create law; adoption by the House likely, but it cannot become law as written.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether House will adopt by voice or need recorded vote
  • Existence or filing of a companion Senate resolution
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Left emphasizes need for funding and access commitments

Text is a nonbinding House resolution that does not create law; adoption by the House likely, but it cannot become law as written.

Unlocked analysis

Relative to its intended legislative type, this bill functions as a conventional commemorative resolution: it provides a substantive factual preamble and then issues declarative support for designating April 5, 2026 as…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis